All In Biotech

Drug Trial Radar · NCT01202279

Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Safety and Efficacy of Mucinex D for Symptomatic Therapy in Patients With Acute Upper Respiratory Tract Who Seek Treatment

Last checked: Nov 20, 2026Latest source record: Dec 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,179 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,179

Actual

Start

Oct 2009

Primary completion

Apr 2010

Study completion Jul 2010

Sponsor

Lead sponsor
Reckitt Benckiser Inc.Industry
Sponsor type
Industry
First posted
Sep 15, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if treatment with Mucinex D lowers the use of antibiotics in the treatment of upper respiratory infection when compared to placebo

Conditions

  • Acute Upper Respiratory Track Infection

Interventions

  • GuaifenesinDrug

    1200 mg guaifenesin and 120 mg pseudoephedrine HCl bid for 7 days

  • PlaceboDevice

    Placebo bid for 7 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Antibiotic SparingTime frame: Day 7
  2. Change From Baseline in Total Symptom Score of the Wisconsin Upper Respiratory Symptom Survey - 21 (WURSS-21).Time frame: Baseline and 7 Days

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Advantage, Inc.

    Mesa, Arizona

  • Med Center

    Carmichael, California

  • Research Center of Fresno, 3636 N. First Street, Suite 141

    Fresno, California

  • Coastal Medical Research Group, Inc., 47 Santa Rosa Street

    San Luis Obispo, California

  • Coastal Connecticut Research, LLC, 342 Montauk Avenue

    New London, Connecticut

  • Glasgow Family Practice

    Newark, Delaware

  • Koch Family Medicine, 81A E. Queenwood Road

    Morton, Illinois

  • Sterling Research Group, Ltd., 650 Sprucewood Lane

    Erlanger, Kentucky

  • Clinical Associates Research, 750 Main Street, Suite 310

    Reisterstown, Maryland

  • Park Place Family Practice & Internal Medicine

    Taylor, Michigan

  • Immedicenter

    Bloomfield, New Jersey

  • Peters Medical Research

    High Point, North Carolina

  • (Piedmont Medical Research Assoc., Inc. d/b/a), Crescent Medical Research

    Salisbury, North Carolina

  • Parsons Avenue Medical Clinic

    Columbus, Ohio

  • Legacy Clinical Research, LLC, 1204 W. Willow Road, Suite B

    Enid, Oklahoma

  • Integrated Medical Research, PC

    Ashland, Oregon

  • Harleysville Medical Associates, 176 Main Street

    Harleysville, Pennsylvania

  • Kastelic MD & Associates, 322 Warren Street, Suite 300

    Johnstown, Pennsylvania

  • Durham Physicians, P.C.

    Penndel, Pennsylvania

  • Palmetto Medical Research, 180 Wingo Way, Suite 203

    Mt. Pleasant, South Carolina

  • TriCities Medical Research

    Bristol, Tennessee

  • Village Health Partners

    Plano, Texas

  • Independence Family Medicine, 813 Independence Blvd., Suite A

    Virginia Beach, Virginia

  • Amherst Family Practice, 1867 Amherst Street

    Winchester, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.